These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6315322)

  • 1. [Nicotinic cholinergic receptor and myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Aug; 16(4):250-3. PubMed ID: 6315322
    [No Abstract]   [Full Text] [Related]  

  • 2. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the understanding of myasthenia gravis pathogenesis.
    Heilbronn E
    Prog Clin Biol Res; 1980; 39():391-405. PubMed ID: 6995993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 5. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Gomez CM; Marton LS
    N Engl J Med; 1985 Jan; 312(4):221-5. PubMed ID: 2578213
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis, the acetylcholine receptor and the immune response.
    Barkas T
    Int J Immunopharmacol; 1979; 1(4):263-71. PubMed ID: 162144
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: pathogenesis and treatment.
    Richman DP; Agius MA
    Semin Neurol; 1994 Jun; 14(2):106-10. PubMed ID: 7984824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
    Newsom-Davis J; Willcox N; Schluep M; Harcourt G; Vincent A; Mossman S; Wray D; Burges J
    Ann N Y Acad Sci; 1987; 505():12-26. PubMed ID: 2825574
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor T cells in myasthenia gravis.
    Clementi F; Gotti C; Mori L; Ricciardi-Castagnoli P
    Monogr Allergy; 1988; 25():41-9. PubMed ID: 2971877
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis].
    Alfaro A; Peñarrocha M
    Med Clin (Barc); 1984 Mar; 82(10):462-9. PubMed ID: 6325833
    [No Abstract]   [Full Text] [Related]  

  • 19. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Marton LS
    Ann N Y Acad Sci; 1987; 505():451-60. PubMed ID: 2446557
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis.
    Sher E; Gotti C; Clementi F
    Ann Ist Super Sanita; 1988; 24(1):103-16. PubMed ID: 3289434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.